Search Within

Pediatrics, Department of

Formats
  1. Journal Article (2912)
  2. Meeting Abstract (1920)
  3. Review (143)
  4. Book Section (127)
  5. Editorial (63)
  6. Conference Paper (53)
  7. Research Letter (35)
  8. Correspondence (25)
  9. Guidelines (25)
  10. Miscellaneous (11)
  11. Book Whole (4)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (2096)
  2. GSK Faculty (2002)
  3. Center for Hematologic Malignancies (1923)
  4. Stem Cell Transplantation and Cellular Therapy Service (1651)
  5. Department of Medicine (1598)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (1571)

More Groups

People
  1. Richard O'Reilly (748)
  2. Nai-Kong Cheung (653)
  3. Nancy Kernan (512)
  4. Michael La Quaglia (413)
  5. David Abramson (395)
  6. Ira Dunkel (375)

More People

Years
  1. 2026 (1)
  2. 2025 (141)
  3. 2024 (247)
  4. 2023 (272)
  5. 2022 (332)
  6. 2021 (278)

More Years

Publications
  1. Blood (621)
  2. Journal of Clinical Oncology (432)
  3. Pediatric Blood and Cancer (421)
  4. Biology of Blood and Marrow Transplantation (265)
  5. Neuro-Oncology (236)
  6. Cancer Research (129)

More Publications

Publishers
  1. American Society of Hematology (678)
  2. Elsevier Inc. (665)
  3. American Society of Clinical Oncology (466)
  4. Wiley Periodicals, Inc (435)
  5. Oxford University Press (341)
  6. American Association for Cancer Research (318)

More Publishers

Results (5318)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • INteractive survivorship program to improve health care REsources [INSPIRE]: A study protocol testing a digital intervention with stepped care telehealth to improve outcomes for adolescent and young adult survivors
    Journal Article

    Yi, J. C.; Ballard, S.; Walsh, C.; Friedman, D. N.; Ganz, P. A.; Jacobs, L. A.; Partridge, A. H.; Mitchell, S. A.; Leisenring, W. M.; Syrjala, K. L.; more...
    Contemporary Clinical Trials (2025)

    Fulltext@MSK | Save
  • Stop and think: A case study illustrating the implementation of Bright IDEAS-YA being delivered via telehealth to a young adult cancer patient
    Journal Article

    Reese, S.; Bono, M. H.; Diaz, D. B.; Donovan, K. A.; Sahler, O. J. Z.; Barnett, M. E.; Levonyan-Radloff, K.; Devine, K. A.
    Journal of Clinical Psychology in Medical Settings (2025)

    Fulltext@MSK | Save
  • Effect of clofarabine and fludarabine exposure on outcome after pediatric allogeneic hematopoietic cell transplantation
    Research Letter

    Dekker, L.; de Koning, C. C. H.; Nijstad, A. L.; van der Elst, K. C. M.; Admiraal, R.; Versluijs, A. B.; Boelens, J. J.; Huitema, A. D. R.; Lindemans, C. A.; Nierkens, S.
    Blood Neoplasia (2024)

    Fulltext@MSK | Save
  • Blood biomarkers in retinoblastoma
    Book Section

    Babij, R.; Abramson, D. H.; Francis, J. H.
    In Berry, J. L.; Damato, B. E.; Singh, A. D. (Eds.) Clinical Ophthalmic Oncology: Retinoblastoma. 4th ed (2024)

    Fulltext@MSK | Save
  • Retinoblastoma: Metastatic disease
    Book Section

    Dunkel, I. J.; Chantada, G. L.
    In Berry, J. L.; Damato, B. E.; Singh, A. D. (Eds.) Clinical Ophthalmic Oncology: Retinoblastoma. 4th ed (2024)

    Fulltext@MSK | Save
  • A multi-site break through cancer trial: Phase II study investigating dual inhibition of BCL2 and menin in AML MRD using the combination of venetoclax and revumenib (trial in progress)
    Meeting Abstract

    Issa, G. C.; Ambinder, A. J.; Xiao, W.; Manalis, S.; Shalek, A. K.; Gondek, L. P.; Kentsis, A.; Short, N. J.; Daver, N.; Ning, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A phase II study of the menin inhibitor revumenib in leukemia associated with upregulation of HOX genes: Trial in progress
    Meeting Abstract

    Issa, G. C.; Chin, K. K.; Blachly, J. S.; Farhat, A.; Xiao, L.; Ning, J.; Cuglievan, B.; Shukla, N.; Sasaki, K.; Loghavi, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Safety and efficacy in pediatric patients with relapsed/refractory classic Hodgkin lymphoma enrolled on an intergroup randomized phase II study of the combinations of ipilimumab, nivolumab and brentuximab vedotin (E4412)
    Meeting Abstract

    Forlenza, C. J.; Jegede, O.; Ansell, S. M.; Steidl, C.; Natkunam, Y.; Scott, D. W.; Mehta-Shah, N.; Amengual, J. E.; Cole, P. D.; Kahl, B. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Retrospective cohort analysis of response and survival of children, adolescents, and young adults (CAYA) with relapsed and/or refractory (R/R) T-cell acute lymphoblastic leukemia (T-ALL) and lymphoma (T-LL) treated with curative intent: A TACL consortium study
    Meeting Abstract

    Pauly, M. G.; Chi, Y. Y.; Malvar, J.; Leong, R.; Colace, S.; Gossai, N.; Hijiya, N.; Parekh, C.; Rheingold, S. R.; Verma, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Uncovering the HOXA9 translational regulatory complex that promotes AML leukemic stem cells
    Meeting Abstract

    Xie, X.; Chavez, F. H.; Baali, I.; Chu, E. L.; Evans, C.; Yang, X.; Wei, W.; Luo, H.; Park, S. M.; Chang, K.; more...
    Blood (2024)

    Fulltext@MSK | Save